Zhuoyuan Xin

Zhuoyuan Xin

Auto-generated profile, based on publicly available information

Zhuoyuan Xin

Department of Laboratory Medicine Center, China-Japan Union Hospital, Jilin University, Changchun, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2017 in Cell Cycle
Verified
Journal Article
Closed access
SRShuangchun Ren
Shuangchun Ren
ZXZhuoyuan Xin
Zhuoyuan Xin
YXYinyan Xu
Yinyan Xu
JXJianting Xu
Jianting Xu
GWGuoqing Wang
Guoqing Wang
Liver cancer is the sixth most prevalent cancer, and the third most frequent cause of cancer-related deaths. Circular RNAs (circRNAs), a kind of special endogenous ncRNAs, have been coming back to the forefront of cancer genomics research. In this study, we used a systems biology approach to construct and analyze the circRNA molecular regulatory networks in the context of liver cancer. We detected a total of 127 differentially expressed circRNAs and 3,235 differentially expressed mRNAs. We selected the top-5 upregulated circRNAs to construct a circRNA-miRNA-mRNA network. We enriched the pathways and gene ontology items and determined their participation in cancer-related pathways such as p53 signaling pathway and pathways involved in angiogenesis and cell cycle. Quantitative real-time PCR was performed to verify the top-five circRNAs. ROC analysis showed circZFR, circFUT8, circIPO11 could significantly distinguish the cancer samples, with an AUC of 0.7069, 0.7575, and 0.7103, respectively. Our results suggest the circRNA-miRNA-mRNA network may help us further understand the molecular mechanisms of tumor progression in liver cancer, and reveal novel biomarkers and therapeutic targets.

20 September 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
SYShengman Yu
Shengman Yu
XLXiaoyan Li
Xiaoyan Li
ZXZhuoyuan Xin
Zhuoyuan Xin
LSLiyuan Sun
Liyuan Sun
JSJingwei Shi
Jingwei Shi
At the end of 2019, the COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection, seriously damaged world public health security. Several protein markers associated with virus infection have been extensively explored to combat the ever-increasing challenge posed by SARS-CoV-2. The proteomics of COVID-19 deepened our understanding of viral particles and their mechanisms of host invasion, providing us with information on protein changes in host tissues, cells and body fluids following infection in COVID-19 patients. In this review, we summarize the proteomic studies of SARS-CoV-2 infection and review the current understanding of COVID-19 in terms of the quantitative and qualitative proteomics of viral particles and host entry factors from the perspective of protein pathological changes in the organism following host infection.